Final Word - BioPharm International

ADVERTISEMENT

Final Word
  • Managing the Global Supply Chain



    Recent problems with food and pharmaceutical ingredients sourced from China highlight a major disadvantage of our complex international supply chains for food and drug ingredients. A global supply chain offers more opportunities for accidental contamination as well as intentional adulteration and counterfeiting. Sticking to minimal requirements may not be enough.

    Pharmaceutical Quality Success: It's All About Management


    Engaging executive leadership in the quality process is the key to compliance success.

    Can the FDA Live up to its Promise of a Risk-Based Approach to Compliance?


    The expanding globalization of the industry poses a challenge for international enforcement.

    The Role of Analytical Science in the Debate over Biosimilars



    Both innovator and generics companies are using analytics to support comparability arguments.

    Evaluating China's Intellectual Property Situation



    The Chinese government is making consistent efforts to strengthen IP protection.

    Has the Era of Blockbuster Drugs Come to an End?



    Eighty drugs will lose patent protection between 2007 and 2011.

    How to Develop a Pool of Talented People



    CMOs must take a proactive approach to ensure the availability of local talent

    Back to the Future



    One company even connected hollow fiber cell culture chambers to living cows.

    Final Word: Outsourcing in Today's Risk-Based Environment



    Outsourcing has been a cornerstone of our industry for decades.

ADVERTISEMENT

ADVERTISEMENT

Advertiser Gallery
Click here